Advertisement

Topics

STAT Plus: GSK’s new shingles vaccine may win nod over Merck’s Zostavax

04:30 EDT 19 Oct 2017 | STAT

October is shaping up to be a momentous month for GlaxoSmithKline’s new shingles vaccine, Shingrix. The Food and Drug Administration may approve the vaccine for the U.S. market by the…

Original Article: STAT Plus: GSK’s new shingles vaccine may win nod over Merck’s Zostavax

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: GSK’s new shingles vaccine may win nod over Merck’s Zostavax"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...